# MITOTHERAPEUTIX, LLC: cGMP Production, IND-enabling studies, and Phase I Clinical Studies to Test a Novel siRNA drug product for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | MITOTHERAPEUTIX, LLC |
| Location | CHESHIRE, CT |
| Project | cGMP Production, IND-enabling studies, and Phase I Clinical Studies to Test a Novel siRNA drug product for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) |
| Project number | 2R44DK129102-04A1 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $996,169 |
| Awarded | 2026-09-17 |
| Project period | 2021-06-01 to 2029-07-31 |
| UEI | QNXLAMDAM5Y4 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312337). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.